SXTP
NASDAQ · Pharmaceuticals
60 Degrees Pharma Inc
$1.54
-0.04 (-2.53%)
Open$1.58
Previous Close$1.58
Day High$1.59
Day Low$1.53
52W High$14.68
52W Low$1.29
Volume—
Avg Volume46.3K
Market Cap4.17M
P/E Ratio—
EPS$-15.22
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+72.7% upside
Current
$1.54
$1.54
Target
$2.66
$2.66
$2.13
$2.66 avg
$3.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 15.05M | 31.67M | 862.6K |
| Net Income | -175,494,752 | -332,446,383 | 198.9K |
| Profit Margin | -1,166.4% | -1,108.1% | 23.1% |
| EBITDA | -212,033,677 | -423,978,095 | 334.7K |
| Free Cash Flow | — | — | 224.8K |
| Rev Growth | -52.5% | -52.5% | -6.7% |
| Debt/Equity | 0.04 | 0.04 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |